Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer
(2025) Prostate Cancer and Prostatic Diseases — (2025)
Files
Ravi_PCPD_202539779964.pdf
Open Access - Adobe PDF
- 462.02 KB
Details
- Authors
Ravi, Praful 
- Affiliations
Citations
Ravi, P., Xie, W., Gillessen, S., Tombal, B., Spratt, D. E., Nguyen, P. L., & Sweeney, C. J. (2025). Evaluation of clinical risk stratification to determine benefit from long-term versus short-term androgen deprivation in high-risk localized prostate cancer. Prostate Cancer and Prostatic Diseases. Submitted. https://doi.org/10.1038/s41391-025-00937-0 (Original work published 2025)